Long-term debt · Fiscal year 2025
| 1 | UnitedHealth GroupUNH | $72.3B |
|---|---|---|
| 2 | AbbVieABBV | $64.5B |
| 3 | PfizerPFE | $61.6B |
| 4 | CVS HealthCVS | $60.5B |
| 5 | AmgenAMGN | $50.0B |
| 6 | MerckMRK | $46.8B |
| 7 | Bristol Myers SquibbBMY | $42.9B |
| 8 | HCA HealthcareHCA | $41.6B |
| 9 | Eli LillyLLY | $40.9B |
| 10 | Johnson & JohnsonJNJ | $39.4B |